These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 27492939)

  • 1. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    Adamsson Eryd S; Gudbjörnsdottir S; Manhem K; Rosengren A; Svensson AM; Miftaraj M; Franzén S; Björck S
    BMJ; 2016 Aug; 354():i4070. PubMed ID: 27492939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    Pasternak B; Ueda P; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Wintzell V; Melbye M; Svanström H
    BMJ; 2019 Aug; 366():l4772. PubMed ID: 31467044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
    Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
    Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.
    Hero C; Rawshani A; Svensson AM; Franzén S; Eliasson B; Eeg-Olofsson K; Gudbjörnsdottir S
    Diabetes Care; 2016 Jun; 39(6):996-1003. PubMed ID: 27208327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
    Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
    JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations: A Pooled Individual Patient Data Analysis.
    Aggarwal R; Steinkamp J; Chiu N; Petrie B; Mirzan H
    Hypertension; 2018 May; 71(5):833-839. PubMed ID: 29531175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.
    Svanström H; Ueda P; Melbye M; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Pasternak B
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):106-114. PubMed ID: 30527909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register.
    Cederholm J; Gudbjörnsdottir S; Eliasson B; Zethelius B; Eeg-Olofsson K; Nilsson PM;
    J Hypertens; 2010 Oct; 28(10):2026-35. PubMed ID: 20634718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.
    Ferreira JP; Duarte K; Pfeffer MA; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Eur J Heart Fail; 2018 Feb; 20(2):323-331. PubMed ID: 29314455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
    Holzmann MJ; Sartipy U
    Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
    Rawshani A; Sattar N; Franzén S; Rawshani A; Hattersley AT; Svensson AM; Eliasson B; Gudbjörnsdottir S
    Lancet; 2018 Aug; 392(10146):477-486. PubMed ID: 30129464
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.